Rivatas (Rivastigmine) 15MG is a higher-strength formulation of the cholinesterase inhibitor used to manage symptoms of mild to moderate dementia in Alzheimer's and Parkinson's disease patients. This medication enhances acetylcholine levels in the brain, improving cognitive function, memory retention, and daily task performance. The 15MG dosage is suitable for patients who require a stronger therapeutic effect or have been stabilized on a lower dose. Rivatas helps slow the progression of dementia-related symptoms, providing patients with better quality of life and independence.